Vasant Narasimhan

Vasant "Vas" Narasimhan is an Indian-American physician and the chief executive officer of Novartis (since 2018).[1][2][3][4]

Vasant Kalathur Narasimhan

M.D.
Vasanth Narasimhan in 2018
BornAugust 26, 1976
Pittsburgh, PA
NationalityAmerican
EducationUniversity of Chicago
Harvard Medical School
OccupationCEO of Novartis
Medical career
ProfessionPhysician
InstitutionsNovartis

Biography

Narasimhan received his bachelor's degree in biological sciences from University of Chicago, his M.D. from Harvard Medical School and his master's degree in public policy from the John F. Kennedy School of Government.[5]

Narasimhan has previously served as Global Head of Biopharmaceuticals & Oncology Injectables at Sandoz International.[6]

Narasimhan joined Novartis in 2005.[6] From 2014 to 2016, he served as the Global Head of Development for Novartis Pharmaceuticals. From 2016 to 2018, he held the role of Global Head of Drug Development and Chief Medical Officer within the company.[6] On September 5, 2017, he was named the successor of Joseph Jimenez as CEO of Novartis.[7]

He is a member of the U.S. National Academy of Medicine and a member of the board of fellows of Harvard Medical School. [8] He also serves on the boards of African Parks, a nonprofit conservation organization, and of the Pharmaceutical Research and Manufacturers of America.[9][10]

In 2015, Fortune listed Narasimhan 7th in their '40 under 40' list.[11]

Personal life

Narasimhan is married to Srishti Gupta, who met him at Harvard while organizing an Asian cultural festival.[12] His parents originate from Tamil Nadu, India having immigrated to the United States in the 1970s.[1] Narasimhan's mother is a former nuclear engineer for Public Service Electric and Gas and his father was an executive at Hoeganaes Corporation.[13]

References
  1. Phadnis, Aneesh (2017-09-05). "Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis". Business Standard India. Retrieved 2018-08-15.
  2. Bisserbe, Noemie (2018-02-18). "Novartis CEO Steers Drug Maker Back to R&D". Wall Street Journal. ISSN 0099-9660. Retrieved 2018-08-15.
  3. Phadnis, Aneesh (5 September 2017). "Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis". Business Standard India. Retrieved 25 November 2019.
  4. Dandekar, Vikas; Sukumar, C. R. (21 August 2018). "There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis". The Economic Times. Retrieved 25 November 2019.
  5. "Vasant (Vas) Narasimhan" (PDF). Novartis. Retrieved 5 September 2017.
  6. "Executive Profile – Vasant Narasimhan". Bloomberg. Retrieved 15 August 2018.
  7. "Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor". Bloomberg.com. Bloomberg Technology. 4 September 2017. Retrieved 5 September 2017.
  8. "Authors". World Economic Forum. Retrieved 2018-08-15.
  9. "Vasant (Vas) Narasimhan, M.D." www.africanparks.org. Retrieved 2020-09-24.
  10. "Our Leadership". www.phrma.org. Retrieved 2020-09-24.
  11. "Vas Narasimhan". Fortune. 2015-09-24. Retrieved 2018-08-15.
  12. "WEDDINGS/CELEBRATIONS; Srishti Gupta, Vasant Narasimhan". The New York Times. 2003-03-16. ISSN 0362-4331. Retrieved 2020-09-24.
  13. "WEDDINGS/CELEBRATIONS; Srishti Gupta, Vasant Narasimhan". The New York Times. 16 March 2003. Retrieved 5 September 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.